Partnerships with health organizations that have a shared vision and commonality in gynecologic oncology are essential to accomplishing the society’s strategic goals. Alliances with organizations whose goals align with those of the IGCS strengthen our message and broaden the reach of our mission to enhance the care of women with gynecologic cancer worldwide through education, training and public awareness.
IGCS is eager to develop unique partnerships to support the mission of the Society. To learn more about how you can partner with the IGCS, please contact Mary Eiken, CEO, at firstname.lastname@example.org
WHO’s primary role is to direct and coordinate international health within the United Nations system. The main areas of work are health systems; health through the life-course; noncommunicable and communicable diseases; preparedness, surveillance and response; and corporate services. IGCS is partnering with WHO on the global call for action towards the elimination of cervical cancer.
AORTIC is a non-governmental organization dedicated to the promotion of cancer control and palliation in Africa. Executive members volunteer as knowledge workers for the plight of cancer patients in Africa. AORTIC strives to unite the African continent in achieving its goal of a cancer-free Africa, and seek to make a positive impact throughout the region through collaboration with health ministries and global cancer organizations.
The mission of AAGL is to focus on the ultimate goal of improving patient care in gynecologic medicine, recognizing that surgical gynecologists and other clinicians require lifelong learning. IGCS partnered with the AAGL to provide our members with access to their online surgical video library, SurgeryU. Our partnership will continue to grow and evolve to other important areas within both organizations.
AECA is coordinated through Fox Chase Cancer Center, a National Cancer Institute Designated Cancer Center and functions as the primary driver of scientific exchange between the U.S. and Eurasian research centers. They are an engaged partner and major contributor to the development of cancer control, research and palliative care initiatives within the Russian Federation, Central Asia (Kazakhstan, Uzbekistan, Kyrgyzstan, Tajikistan), Central Europe (Ukraine, Moldova, Belarus), Baltics (Lithuania, Latvia, Estonia), and Caucasus (Armenia, Georgia, Azerbaijan).
IGCS’s partnership with the AECA has facilitated critical discussions to improve further scientific research, clinical mentorship training, and healthcare delivery related to gynecologic cancers. Foundations for this work were developed at the Inaugural International Conference ‘Current Concepts and Controversies in Gynecologic and Urologic Oncology’ held in Minsk, Belarus in 2017.
ASCO is a professional organization for physicians and oncology professionals caring for people with cancer. ASCO’s mission is to conquer cancer through research, education, and promotion of the highest quality patient care.
ESGO, Europe’s leading non-profit gynaecology oncology society, strives to improve gynaecological cancer care by providing training standards, educational opportunities and breakthroughs in the prevention, treatment and study of gynaecological oncology. IGCS is proud to partner with ESGO in the joint publication of the International Journal of Gynecological Cancer (IJGC) and other educational initiatives.
The Gynecological Cancer InterGroup aims to promote and facilitate high quality clinical trials in order to improve outcomes for women with gynecological cancer. GCIG conducts trials through the Cervical Cancer Research Network (CCRN). The Cervix Cancer Research Network (CCRN) is a multi-national, multi-institution consortium of physicians and scientists focused on improving cervical cancer outcomes worldwide by making publicly funded, multinational cancer clinical trials available to patients in low- and middle-income countries.
IGCS supports the mission of GCIG by partnering in clinical trial education, access to trials and dissemination of information derived from trials.
ISSTD aims to forge international collaborations between cooperative groups to improve the outcomes of women with trophoblastic diseases through education, research, and where possible clinical-trial development in a highly constructive and cost-effective manner. IGCS entered into a strategic partnership with ISSTD in 2020 with objectives to collaborate on early career research and professional development, mentorship and training programs, education, advocacy, and data collection methods.
The National Cancer Institute (NCI) established the Center for Global Health (CGH) in 2011 to help reduce the global burden of cancer. CGH develops initiatives and collaborates with other NCI divisions, NCI-designated cancer centers, and countries to support cancer control planning build capacity, and support cancer research and cancer research networks in low- and middle-income countries (LMICs).
The National Comprehensive Cancer Network® (NCCN®) is an alliance of 27 of the world’s leading cancer centers, working together to develop treatment guidelines for most cancers, and dedicated to research that improves the quality, effectiveness, and efficiency of cancer care. The core resources made available by NCCN are the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®).To make the Guidelines more relevant in low and middle resource settings, NCCN began publication of NCCN Frameworks for Resource Stratification. In partnership with the IGCS, these Guidelines will be tested and updated accordingly to provide meaningful information to members practicing in resource stratified regions of the world.
The organisation is dedicated to taking the lead in convening, capacity building and advocacy initiatives that unite and support the cancer community to reduce the global cancer burden, promote greater equity, and to ensure cancer control continues to be a priority in the world health and development agenda. IGCS is a proud member of the UICC which strengthens our relationships, amplifies our message, and allows greater representation of gynecologic cancers on the global health agenda.
The World Ovarian Cancer Coalition is a not-for-profit organization, working across the globe towards a world where every woman with ovarian cancer has the best chance of survival, and the best quality of life – wherever she may live. WOCC builds on the significant impact of the annual flagship ovarian cancer awareness campaign – World Ovarian Cancer Day, started in 2013 and their ground-breaking Every Woman Study™ published in 2018.
Strategic Alliance Partners
As partners, each regional group gains special benefits for their individual group members as well as the opportunity to discuss important issues with the IGCS leadership and industry partners. The Strategic Alliance Partnership program is meant to provide mutual benefits to the alliance partner groups, the individual IGCS members and the society as a whole, helping us all to meet challenges facing the global gynecologic cancer community and develop solutions as a team. Learn more about the Strategic Alliance Partnership Program.
Asociación Colombiana de Ginecólogos Oncólogos
Association of Oncologists of the Republic of Kazakhstan
Association of Oncologists of Uzbekistan
Belarusian Society of Oncologists (Gyn Oncology Branch)
Brazilian Society of Surgical Oncology
Chinese Gynecologic Cancer Society
Indonesian Society of Gynecologic Oncology
Israeli Society of Gynecological Oncology
Mexican College of Gynecologic Oncologists
Middle East and Mediterranean Association of Gynecologic Oncologists
Pan-Arabian Research Society of Gynecologic Oncology
South African Society of Gynaecologic Oncology
Thai Gynecologic Cancer Society
The International Society of Gynecological Pathologists
The Society of Gynecologic Oncology of Canada
The Society of Gynecologic Oncologists of the Philippines